Table 5 Associations of two polymorphism models in the CD160 gene with HT before and after adjusting for confounders
From: Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study
Comparison models | Unadjusted estimates | Adjusted estimatesa | ||
|---|---|---|---|---|
OR (95%CI) | P values | OR (95%CI) | P values | |
rs744877 | ||||
Allele Model | 0.95 (0.79–1.14) | 0.585 | 0.95 (0.79–1.16) | 0.632 |
Dominant Model | 1.06 (0.82–1.37) | 0.664 | 1.07 (0.82–1.40) | 0.615 |
Recessive model | 1.09 (0.74–1.61) | 0.669 | 1.11 (0.73–1.67) | 0.629 |
Homozygous model | 1.01 (0.67–1.52) | 0.972 | 1.04 (0.68–1.60) | 0.860 |
Additive model | 0.86 (0.67–1.11) | 0.244 | 0.86 (0.66–1.12) | 0.262 |
rs3766526 | ||||
Allele Model | 1.06 (0.85–1.32) | 0.631 | 1.09 (0.86–1.39) | 0.457 |
Dominant Model | 0.89 (0.69–1.13) | 0.325 | 0.89 (0.69–1.14) | 0.354 |
Recessive model | 1.12 (0.55–2.27) | 0.750 | 1.46 (0.69–3.09) | 0.322 |
Homozygous model | 1.14 (0.56–2.31) | 0.719 | 1.45 (0.69–3.08) | 0.328 |
Additive model | 1.05 (0.81–1.37) | 0.713 | 1.04 (0.79–1.37) | 0.785 |